Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2010

01-06-2010 | Case Report

Factor VII Deficiency: A Rare Case Report

Authors: Ramanath Mahale, Pankaj Rathi, Chetan Ginegiri, Rajiv Aggarwal

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2010

Login to get access

Abstract

Factor VII deficiency is a rare congenital coagulopathy. Prolonged prothrombin time with normal partial thromboplastin time indicates factor VII deficiency. For the definitive diagnosis, the specific factor VII level should be investigated. We report a 20 day old, baby girl, born full-term who was admitted with the diagnosis of sepsis. Hematological tests revealed prolonged prothrombin time and a factor VII level of nine percent. After antibiotic therapy and fresh frozen plasma replacement, her clinical status improved but the prothrombin time continued to be prolonged. On the seventh day of discharge the baby died due to sudden intracranial hemorrhage.
Literature
1.
go back to reference Alexander B, Goldstein R, Landwehr G et al (1951) Congenital SPCA deficiency: a hitherto unrecognised coagulation defect with haemorrhage rectified by serum, serum fractions. J Clin Invest 30:956 Alexander B, Goldstein R, Landwehr G et al (1951) Congenital SPCA deficiency: a hitherto unrecognised coagulation defect with haemorrhage rectified by serum, serum fractions. J Clin Invest 30:956
2.
go back to reference Jagruti PS, Mamta NM, Bavdekar SB, Ramesh CP (2004) Congenital factor VII deficiency. Indian J Pediatr 71(5):441–443CrossRef Jagruti PS, Mamta NM, Bavdekar SB, Ramesh CP (2004) Congenital factor VII deficiency. Indian J Pediatr 71(5):441–443CrossRef
3.
go back to reference Cooper DN, Millar DS, Wacey A et al (1997) Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 78:151–160PubMed Cooper DN, Millar DS, Wacey A et al (1997) Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 78:151–160PubMed
4.
go back to reference Mariani G, LoCoco L, Bernadi F et al (1998) Molecular and clinical aspects of factor VII deficiency. Blood Coag Fibrinol 9(Suppl 1):S83–S88 Mariani G, LoCoco L, Bernadi F et al (1998) Molecular and clinical aspects of factor VII deficiency. Blood Coag Fibrinol 9(Suppl 1):S83–S88
5.
go back to reference Biron C, Bengler C, Gris JC, Schved JF (1997) Acquired isolated factor VII deficiency during sepsis. Haemostasis 27(2):51–56PubMed Biron C, Bengler C, Gris JC, Schved JF (1997) Acquired isolated factor VII deficiency during sepsis. Haemostasis 27(2):51–56PubMed
6.
go back to reference Jeremy G, Vinod KG (2009) Acquired factor VII deficiency in wilms tumor. Pediatr Blood Cancer 52:394–395CrossRef Jeremy G, Vinod KG (2009) Acquired factor VII deficiency in wilms tumor. Pediatr Blood Cancer 52:394–395CrossRef
7.
go back to reference Mariani G, Dolce A, Marchetti G (2004) Clinical picture and management of congenital factor VII deficiency. Hemophilia 10(Suppl 4):180–183CrossRef Mariani G, Dolce A, Marchetti G (2004) Clinical picture and management of congenital factor VII deficiency. Hemophilia 10(Suppl 4):180–183CrossRef
8.
go back to reference Ingerslev J, Kristensen L (1998) Clinical picture and treatment strategies in factor VII deficiency. Hemophilia 4:689–696CrossRef Ingerslev J, Kristensen L (1998) Clinical picture and treatment strategies in factor VII deficiency. Hemophilia 4:689–696CrossRef
Metadata
Title
Factor VII Deficiency: A Rare Case Report
Authors
Ramanath Mahale
Pankaj Rathi
Chetan Ginegiri
Rajiv Aggarwal
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2010
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-010-0023-5

Other articles of this Issue 2/2010

Indian Journal of Hematology and Blood Transfusion 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine